Medical Weight Loss for Sioux City, Iowa Residents
Sioux City, Iowa residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Sioux City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Sioux City Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Sioux City, Iowa residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Sioux City is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Sioux City address.
Patients across Sioux City and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Iowa. We care for patients throughout Downtown and the greater Siouxland area. There is no distance surcharge for Sioux City patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Telehealth removes the distance between Sioux City and specialized care: your consultation happens wherever you are in Iowa. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Sioux City patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Sioux City
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Sioux City
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Sioux City address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Sioux City
Does New Hope Weight Loss treat patients in Sioux City?
Yes. Although the clinic is in Costa Mesa, California, we treat Sioux City, Iowa residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Sioux City?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Sioux City address in cold-pack packaging.
What do Sioux City patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Sioux City do you serve?
We serve patients from across Sioux City by telehealth, including Downtown and the greater Siouxland area.
Are there hidden fees for Sioux City patients?
No. Sioux City patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Sioux City, Iowa by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.